Lanting T. Liu

State Key Laboratory Of Experimental Hematology, Chinese Academy Of Medical Sciences & Peking Union Medical College
Tianjin, 300020, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Identification and transformation of novel targets for immunotherapy in multiple myeloma.

Identification and transformation of novel targets for immunotherapy in multiple myeloma.

Journal: Chinese medical journal

Published: March 30, 2025

Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma.

Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma.

Journal: The Journal of clinical investigation

Published: March 17, 2025

Improving predictive accuracy in multiple myeloma using a plasma cell profile derived from single-cell RNA sequencing.

Improving predictive accuracy in multiple myeloma using a plasma cell profile derived from single-cell RNA sequencing.

Journal: Haematologica

Published: February 17, 2025

A novel indirubin- 3-monoxime derivative I3MV- 8b exhibits remarkable cytotoxicity against multiple myeloma by targeting TRIM28.

A novel indirubin- 3-monoxime derivative I3MV- 8b exhibits remarkable cytotoxicity against multiple myeloma by targeting TRIM28.

Journal: Biomarker research

Published: December 12, 2024

DNp73 enhances tumor progression and immune evasion in multiple myeloma by targeting the MYC and MYCN pathways.

DNp73 enhances tumor progression and immune evasion in multiple myeloma by targeting the MYC and MYCN pathways.

Journal: Frontiers in immunology

Published: July 25, 2024

Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma.

Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma.

Journal: The Journal of clinical investigation

Published: May 15, 2024

LILRB4 represents a promising target for immunotherapy by dual targeting tumor cells and myeloid-derived suppressive cells in multiple myeloma.

LILRB4 represents a promising target for immunotherapy by dual targeting tumor cells and myeloid-derived suppressive cells in multiple myeloma.

Journal: Haematologica

Published: January 20, 2024

CRIP1 involves the pathogenesis of multiple myeloma via dual-regulation of proteasome and autophagy.

CRIP1 involves the pathogenesis of multiple myeloma via dual-regulation of proteasome and autophagy.

Journal: EBioMedicine

Published: August 01, 2023

Diagnostic and prognostic value of serum miR-19a-3p in patients with multiple myeloma

Diagnostic and prognostic value of serum miR-19a-3p in patients with multiple myeloma

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: January 28, 2023

Exosome miRNAs profiling in serum and prognostic evaluation in patients with multiple myeloma.

Exosome miRNAs profiling in serum and prognostic evaluation in patients with multiple myeloma.

Journal: Blood science (Baltimore, Md.)

Published: December 14, 2022

Aberrant metabolic processes promote the immunosuppressive microenvironment in multiple myeloma.

Aberrant metabolic processes promote the immunosuppressive microenvironment in multiple myeloma.

Journal: Frontiers in immunology

Published: October 23, 2022

Single-cell profiles reveal tumor cell heterogeneity and immunosuppressive microenvironment in Waldenström macroglobulinemia.

Single-cell profiles reveal tumor cell heterogeneity and immunosuppressive microenvironment in Waldenström macroglobulinemia.

Journal: Journal of translational medicine

Published: October 02, 2022

Showing 1-12 of 26

Last Updated: 09/26/2026